6 Temporal Lobe Epilepsy Clinical Trials in Philadelphia, PA (2026)

Q: How do I join a clinical trial in Philadelphia?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you.

Recruiting Temporal Lobe Epilepsy Studies in Philadelphia

NCT02817997Recruiting

International Registry for Patients With Castleman Disease

The purpose of this study is to collect clinical, laboratory, and patient survey data from patients with Castleman disease to improve understanding, diagnosis, and treatment of the disease. Funding so...

Philadelphia, PA1,000 participantsUniversity of Pennsylvania

View Study Details

NCT06055439Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

The goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least ...

Philadelphia, PAPHASE1135 participantsChimeric Therapeutics

View Study Details

NCT05932680Recruiting

Limited-duration Teclistamab

This is a single-arm, non-inferiority study in which patients who have achieved a very good partial response (VGPR) or better, according to International Myeloma Working Group (IMWG) response criteria...

Philadelphia, PAPHASE275 participantsAbramson Cancer Center at Penn Medicine

View Study Details

NCT05705024Recruiting

Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells

The proposed Conventional Cohort Expansion Study involves the use of Mesenchymal Stromal Cells (MSCs) are derived from the bone marrow. We previously studied the safety of subconjunctival injection of...

Philadelphia, PAPHASE238 participantsUniversity of Illinois at Chicago

View Study Details

NCT07219407Recruiting

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-l...

Philadelphia, PAPHASE230 participantsRapport Therapeutics Inc.

View Study Details

NCT07085039Recruiting

Ruxolitinib in Previously Treated Idiopathic Multicentric Castleman Disease

The research study is being done to look at the effects of ruxolitinib in adults with idiopathic Multicentric Castleman Disease (iMCD) that has not gotten better from taking siltuximab or tocilizumab,...

Philadelphia, PAPHASE214 participantsUniversity of Pennsylvania

View Study Details

About Temporal Lobe Epilepsy Clinical Trials in Philadelphia

Temporal lobe epilepsy is the most common form of focal epilepsy, with seizures originating in the temporal lobe of the brain. It can cause unusual sensations, memory problems, and altered consciousness. Treatment includes antiseizure medications and surgery for drug-resistant cases.

There are currently 6 temporal lobe epilepsy clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 1,292 participants. Research is being sponsored by University of Pennsylvania, Chimeric Therapeutics, Abramson Cancer Center at Penn Medicine and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Temporal Lobe Epilepsy Clinical Trials in Philadelphia — FAQ

Are there temporal lobe epilepsy clinical trials in Philadelphia?

Yes, there are 6 temporal lobe epilepsy clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Philadelphia?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.

Are clinical trials in Philadelphia free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.

What temporal lobe epilepsy treatments are being tested?

The 6 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for temporal lobe epilepsy.

Data updated October 15, 2026 from ClinicalTrials.gov